Kidney disease study reveals unexpected marker
When University of Texas at Arlington researcher Paul J. Fadel and his colleagues launched a study on vascular health in people with chronic kidney disease, they expected to better understand a long-standing belief. For years, scientists have pointed to a blood marker called ADMA—asymmetric dimethylarginine—as a warning sign for vascular problems.
But the team’s findings, recently published in the American Journal of Physiology-Renal Physiology, told a different story.
Instead, another blood marker, SDMA—symmetric dimethylarginine—long considered mostly inactive, showed a stronger connection to vascular health than ADMA.
“The ...